Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL
NCT02766868
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lymphoblastic Leukemia, Acute, Adult
Interventions
DRUG:
FACE-Flu/Bu/Cy
Sponsor
Shanghai Jiao Tong University School of Medicine